Standout Papers

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as ini... 2009 2026 2014 2020 659
  1. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial (2009)
    S. Vincent Rajkumar, Susanna Jacobus et al. The Lancet Oncology

Immediate Impact

1 by Nobel laureates 37 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Functional CeOx nanoglues for robust atomically dispersed catalysts
2022 StandoutNature
Diagnosis and Management of Multiple Myeloma
2022 Standout
6 intermediate papers

Works of Michael B. Katz being referenced

Novel MEMS-Based Gas-Cell/Heating Specimen Holder Provides Advanced Imaging Capabilities forIn SituReaction Studies
2012
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
2009 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael B. Katz 1022 321 371 612 504 83 2.5k
Tetsushi Matsuda 1250 224 237 94 561 61 3.0k
Jan Visser 1075 72 401 975 1678 123 4.9k
Jinghan Wang 1185 248 413 244 363 68 2.4k
Hiroshi Uchiyama 952 173 712 922 719 157 3.4k
Yoshio Oka 878 88 776 75 320 129 3.0k
Matthias Scheffler 894 43 114 93 939 109 3.6k
Shinji Ogawa 492 107 566 47 666 110 2.7k
U. Vetter 1026 266 217 119 676 146 3.8k
C. Corbel 1715 33 240 280 749 197 4.9k
Xuejun Zhu 516 117 124 111 312 128 2.9k

All Works

Loading papers...

Rankless by CCL
2026